Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2004 |
|---|---|
| Erschienen: |
2004 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
|---|---|
| Enthalten in: |
Bioorganic & medicinal chemistry letters - 14(2004), 10, Seite 2433-2438 |
| Beteiligte Personen: |
White, Alex W. [VerfasserIn] |
|---|
| RVK: |
|---|
| Umfang: |
6 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1662208820 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1662208820 | ||
| 003 | DE-627 | ||
| 005 | 20230707133322.0 | ||
| 007 | tu | ||
| 008 | 040428s2004 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw040428 |
| 035 | |a (DE-627)OLC1662208820 | ||
| 035 | |a (DE-599)GBVOLC1662208820 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 540 |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a VA 2620 |q AVZ |2 rvk | ||
| 100 | 1 | |a White, Alex W. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitors |
| 264 | 1 | |c 2004 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Curtin, Nicola J. |4 oth | |
| 700 | 1 | |a Eastman, Brian W. |4 oth | |
| 700 | 1 | |a Golding, Bernard T. |4 oth | |
| 700 | 1 | |a Hostomsky, Zdenek |4 oth | |
| 700 | 1 | |a Kyle, Suzanne |4 oth | |
| 700 | 1 | |a Li, Jianke |4 oth | |
| 700 | 1 | |a Maegley, Karen A. |4 oth | |
| 700 | 1 | |a Skalitzky, Donald J. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Bioorganic & medicinal chemistry letters |d Amsterdam [u.a.] : Elsevier, 1991 |g 14(2004), 10, Seite 2433-2438 |w (DE-627)130952400 |w (DE-600)1063195-1 |w (DE-576)025097946 |x 0960-894X |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2004 |g number:10 |g pages:2433-2438 |g extent:6 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-CHE | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_130 | ||
| 912 | |a GBV_ILN_285 | ||
| 912 | |a GBV_ILN_2007 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4306 | ||
| 912 | |a GBV_ILN_4323 | ||
| 936 | r | v | |a VA 2620 |
| 951 | |a AR | ||
| 952 | |d 14 |j 2004 |e 10 |h 2433-2438 |g 6 | ||